1154760-03-8 Usage
General Description
2-(N-tert-butoxycarbonyl-3-hydroxyazetidin-3-yl)acetic acid is a chemical compound with the molecular formula C12H19NO6. It is a derivative of azetidin-3-yl acetic acid and is often used in pharmaceutical research and development. 2-(N-tert-butoxycarbonyl-3-hydroxyazetidin-3-yl)acetic acid is a potential intermediate in the synthesis of various biologically active molecules and is particularly important in the field of medicinal chemistry. The N-tert-butoxycarbonyl (Boc) protective group on the azetidine nitrogen is commonly used in organic synthesis to protect amine groups from unwanted reactions and is often removed under mild acidic conditions. The hydroxy group and acetic acid moiety in this compound also make it a versatile building block for the synthesis of a wide range of pharmaceuticals and biologically active compounds. Overall, 2-(N-tert-butoxycarbonyl-3-hydroxyazetidin-3-yl)acetic acid has a significant role in the development of new drug molecules and biologically active compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1154760-03-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,4,7,6 and 0 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1154760-03:
(9*1)+(8*1)+(7*5)+(6*4)+(5*7)+(4*6)+(3*0)+(2*0)+(1*3)=138
138 % 10 = 8
So 1154760-03-8 is a valid CAS Registry Number.
1154760-03-8Relevant articles and documents
FUMAGILLOL HETEROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME
-
Paragraph 00181, (2017/03/08)
Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS
-
Page/Page column 85, (2011/04/26)
Compounds having antibacterial activity are disclosed. The compounds have the following structure (I): (Formula (I)), including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, R1, R2, R3, Z1 and Z2 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS
-
, (2011/04/26)
Compounds having antibacterial activity are disclosed. The compounds have one of the following structures (I) or (II): including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, R1, R2, R3 and Z1 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
